Unrestricted availability of intracoronary stents is associated with decreased abrupt vascular closure rates and improved early clinical outcomes

Catheterization and Cardiovascular Interventions

Volumn 55, Issue 3, 2002, Pages 294-302

  Suh, W Warren ^a   Grill, Diane E ^a   Rihal, Charanjit S ^a   Bell, Malcolm R ^a   Holmes Jr , David R ^a   Garratt, Kirk N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Abrupt closure; Outcome; Percutaneous transluminal coronary angioplasty; Stents

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE; WARFARIN;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; STENT; THROMBOEMBOLISM; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; COHORT STUDIES; CORONARY RESTENOSIS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 0036198241     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10013     Document Type: Article

References (36)

1. In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty
2. Frequency, management and follow-up of patients with acute coronary occlusions after percutaneous transluminal coronary angioplasty
3. In-hospital cardiac mortality after acute closure after coronary angioplasty: Analysis of risk factors from 8,207 procedure
4. Predictors, therapeutic options and long-term outcome of abrupt reclosure
5. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: The National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry
6. Incidence and consequences of periprocedural occlusion
7. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up
8. Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic, and therapeutic profile
9. Evaluating new devices: Acute (in-hospital) results from the New Approaches of Coronary Intervention Registry
10. Abrupt closure: The CAVEAT I experience. Coronary Angioplasty Versus Excisional Atherectomy Trial
11. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease
12. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease
13. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of platelet IIb/IIIa inhibitor for stenting
14. High-speed rotational atherectomy of human coronary stenoses: Acute and one-year outcomes from the New Approaches to Coronary Intervention (NACI) registry
15. Acute closure during coronary excimer laser angioplasty and conventional balloon dilation: A comparison of management outcome and prediction
16. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings
17. Percutaneous transluminal coronary angioplasty: Initial Mayo Clinic experience
18. Coronary atherectomy: First 50 patients at the Mayo Clinic
19. Percutaneous coronary rotational angioplasty with the Rotablator
20. Extraction atherectomy
21. Excimer laser coronary angioplasty
22. Coronary stenting
23. Grading of angina pectoris
24. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multi-vessel coronary disease. Implications for patient selection
25. Intracoronary thrombus: Role in coronary occlusion complicating percutaneous transluminal coronary angioplasty
26. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty
27. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease
28. Rotational atherectomy multicenter registry: Acute results, complications and 6-month angiographic follow-up in 709 patients
29. Acute complications of excimer laser coronary angioplasty: A detailed analysis of multicenter results
30. Clinical, angiographic and procedural correlates of abrupt vascular closure during coronary intervention. A 10-year experience at Mayo Clinic
31. The changing face of coronary interventional practice: The Mayo Clinic experience
32. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction
33. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology. EPIC and EPILOG investigators. Evaluation of 7E3 for the prevention of ischemic complications. Evaluation of PTCA to improve long-term outcome with abciximab GPIIb/IIIa receptor blockade
34. Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization
35. Clinical risk factors for ischemic complications after percutaneous coronary interventions: Results from the EPIC trial
36. Potential effect of authorization bias on medical record research